Abraxis (Abraxane) for the treatment of cancer
Abraxis is chemotherapy given for treatment of cancer. It is a form of taxane without the proteins that cause allergic reactions.
How It Is Given
Injections are given into the vein given over 30 minutes every three weeks.
Common Side Effects
- Decreased white blood cell count (ANC)
- Hair loss (alopecia)
- Numbness and tingling (neuropathy), which may increase with each treatment
- Increase or decrease in heart rates (ECG abnormalities)
- Muscle and joint pain – most often 2-3 days after treatment
- Increased weakness and decreased strength
Less Common Side Effects
- Nausea and/or vomiting
- Diarrhea
- Mouth sores (mucositis)
- Anemia
Special Concerns
- Abraxane should not be given if your neutrophil count (ANC) is less than 1,500. Blood counts will be monitored.
- Avoid pregnancy while receiving treatment.
- Do not father a child while receiving treatment.
When to Call Your Health Care Provider
- Fever of 100.8°F or greater
- Muscle and joint pain that are not relieved by Tylenol®
- Increased numbness and tingling in hands and feet
The information provided should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Any duplication or distribution of the information contained herein is strictly prohibited.
Last Updated: 09/23/2010
Copyright © 09/23/2010 University of Wisconsin Hospitals and Clinics Authority. All rights reserved. Produced by the Department of Nursing. HF#6226
Print Health Fact For You